Stay updated with breaking news from Inhibitor Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Molecure S.A., a leading biotechnology company focused on drug discovery and development, has unveiled its annual report for 2023 at the start of the new financial year.
/PRNewswire/ -- Expert Systems, a leader in AI-enabled drug discovery, announces the expansion of the collaboration with Eilean Therapeutics as it joins its...
- Phase 2 CSU enrollment complete; topline data by YE 2023 -
SOUTH SAN FRANCISCO, Calif., June 21, 2023 -- Assembly Biosciences, Inc. , a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today... | June 21, 2023
Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program CSF-1R inhibitors show promising anti-tumor activityLead compound shows...